Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

The results of different diagnostic imaging studies used in children with urinary tract infection.

Nasaif MN, Alghamdi AH, Ghamdi JA, Al-Dammas A.

Sudan J Paediatr. 2015;15(1):27-36.

2.

Genetics of Vesicoureteral Reflux.

Nino F, Ilari M, Noviello C, Santoro L, Rätsch IM, Martino A, Cobellis G.

Curr Genomics. 2016 Feb;17(1):70-9. doi: 10.2174/1389202916666151014223507.

3.

Primary vesico-ureteric reflux: The need for individualised risk stratification.

Hidas G, Nam A, Soltani T, Pribish M, Watts B, Khoury AE.

Arab J Urol. 2013 Mar;11(1):8-12. doi: 10.1016/j.aju.2012.11.006. Epub 2013 Jan 24. Review.

4.

Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.

Mattoo TK, Chesney RW, Greenfield SP, Hoberman A, Keren R, Mathews R, Gravens-Mueller L, Ivanova A, Carpenter MA, Moxey-Mims M, Majd M, Ziessman HA; RIVUR Trial Investigators.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):54-61. doi: 10.2215/CJN.05210515. Epub 2015 Nov 10.

PMID:
26555605
5.

Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.

Keren R, Shaikh N, Pohl H, Gravens-Mueller L, Ivanova A, Zaoutis L, Patel M, deBerardinis R, Parker A, Bhatnagar S, Haralam MA, Pope M, Kearney D, Sprague B, Barrera R, Viteri B, Egigueron M, Shah N, Hoberman A.

Pediatrics. 2015 Jul;136(1):e13-21. doi: 10.1542/peds.2015-0409. Epub 2015 Jun 8.

6.

Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity.

Goneau LW, Hannan TJ, MacPhee RA, Schwartz DJ, Macklaim JM, Gloor GB, Razvi H, Reid G, Hultgren SJ, Burton JP.

MBio. 2015 Mar 31;6(2). pii: e00356-15. doi: 10.1128/mBio.00356-15.

7.

Antibiotic prophylaxis and reflux: critical review and assessment.

Baquerizo BV, Peters CA.

F1000Prime Rep. 2014 Nov 4;6:104. doi: 10.12703/P6-104. eCollection 2014. Review.

8.

The RIVUR trial: a factual interpretation of our data.

Mattoo TK, Carpenter MA, Moxey-Mims M, Chesney RW; RIVUR Trial Investigators.

Pediatr Nephrol. 2015 May;30(5):707-12. doi: 10.1007/s00467-014-3022-1. Epub 2015 Jan 6.

9.

The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections.

Becknell B, Schober M, Korbel L, Spencer JD.

Expert Rev Anti Infect Ther. 2015 Jan;13(1):81-90. doi: 10.1586/14787210.2015.986097. Epub 2014 Nov 25. Review.

10.

Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis.

Wang HH, Gbadegesin RA, Foreman JW, Nagaraj SK, Wigfall DR, Wiener JS, Routh JC.

J Urol. 2015 Mar;193(3):963-9. doi: 10.1016/j.juro.2014.08.112. Epub 2014 Sep 6. Review.

11.

Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children.

Robino L, Scavone P, Araujo L, Algorta G, Zunino P, Pírez MC, Vignoli R.

Clin Infect Dis. 2014 Dec 1;59(11):e158-64. doi: 10.1093/cid/ciu634. Epub 2014 Aug 4.

12.

Antimicrobial prophylaxis for children with vesicoureteral reflux.

RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP, Moxey-Mims M, Chesney RW, Carpenter MA.

N Engl J Med. 2014 Jun 19;370(25):2367-76. doi: 10.1056/NEJMoa1401811. Epub 2014 May 4.

13.

Current medical diagnosis and management of vesicoureteral reflux in children.

Celik O, Ipekci T, Aydogdu O, Yucel S.

Nephrourol Mon. 2013 Nov 5;6(1):e13534. doi: 10.5812/numonthly.13534. eCollection 2014 Jan. Review.

14.

Antibiotic resistance in pediatric urology.

Edlin RS, Copp HL.

Ther Adv Urol. 2014 Apr;6(2):54-61. doi: 10.1177/1756287213511508. Review.

15.

Effect of Thymoquinone on Oxidative Stress in Escherichia coli-Induced Pyelonephritis in Rats.

Evirgen O, Gökçe A, Ozturk OH, Nacar E, Onlen Y, Ozer B, Motor VK.

Curr Ther Res Clin Exp. 2011 Oct;72(5):204-15. doi: 10.1016/j.curtheres.2011.09.002.

16.

Revised guidelines on management of antenatal hydronephrosis.

Sinha A, Bagga A, Krishna A, Bajpai M, Srinivas M, Uppal R, Agarwal I.

Indian J Nephrol. 2013 Mar;23(2):83-97. doi: 10.4103/0971-4065.109403.

17.

Endoscopic treatment of vesicoureteral reflux in pediatric patients.

Kim JW, Oh MM.

Korean J Pediatr. 2013 Apr;56(4):145-50. doi: 10.3345/kjp.2013.56.4.145. Epub 2013 Apr 22.

18.

Individualizing management of vesicoureteral reflux.

Cooper CS.

Nephrourol Mon. 2012 Summer;4(3):530-4. doi: 10.5812/numonthly.1866. Epub 2012 Jun 20.

19.

Prevalence and risk factors for renal scars in children with febrile UTI and/or VUR: a cross-sectional observational study of 565 consecutive patients.

Snodgrass WT, Shah A, Yang M, Kwon J, Villanueva C, Traylor J, Pritzker K, Nakonezny PA, Haley RW, Bush NC.

J Pediatr Urol. 2013 Dec;9(6 Pt A):856-63. doi: 10.1016/j.jpurol.2012.11.019. Epub 2013 Mar 7.

20.

Incidence of abnormal imaging and recurrent pyelonephritis after first febrile urinary tract infection in children 2 to 24 months old.

Juliano TM, Stephany HA, Clayton DB, Thomas JC, Pope JC 4th, Adams MC, Brock JW 3rd, Tanaka ST.

J Urol. 2013 Oct;190(4 Suppl):1505-10. doi: 10.1016/j.juro.2013.01.049. Epub 2013 Jan 23.

Items per page

Supplemental Content

Write to the Help Desk